On October 1, 2024, Johanna Roberts, Executive Vice President, General Counsel & Secretary of Penumbra Inc (PEN, Financial), sold 600 shares of the company. The transaction was executed at a price of $190.76 per share, as detailed in the SEC Filing. Following this transaction, the insider now owns 60,488 shares of Penumbra Inc.
Penumbra Inc, a healthcare company, is primarily engaged in the design, development, manufacture, and marketing of innovative medical devices. The company focuses on developing products to treat peripheral vascular and neurovascular diseases.
Over the past year, Johanna Roberts has sold a total of 6,000 shares of Penumbra Inc and has not made any purchases of the stock. This recent sale is part of a broader trend observed within the company, where there have been 25 insider sells and no insider buys over the past year.
The shares of Penumbra Inc were trading at $190.76 on the day of the transaction. The company has a market cap of approximately $7.574 billion. Penumbra's price-earnings ratio stands at 573.50, significantly higher than both the industry median of 30.29 and the company’s historical median.
According to the GF Value, the intrinsic value of Penumbra Inc's stock is estimated at $298.53, suggesting that the stock is Significantly Undervalued with a price-to-GF-Value ratio of 0.64.
The GF Value is calculated based on historical trading multiples like the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted for the company’s past performance and estimated future business outcomes.
This sale by the insider might be of interest to current and potential investors, as it provides insight into the insider's perspective on the stock's current valuation and future prospects.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
